Procoagulant Activity of Blood and Microvesicles Is Disturbed by Pneumococcal Pneumolysin, Which Interacts with

Sonja Oehmcke-Hecht1, Claudia Maletzki2, Surabhi Surabhi3

  • 1Institute of Medical Microbiology, Virology and Hygiene, Rostock University Medical Center, Rostock, Germany.

Insights

Streptococcus pneumoniae impairs blood coagulation by releasing pneumolysin, which lyses mononuclear cells. This interaction, involving the innate immune and coagulation systems, may worsen lung injury during pneumonia.

Area of Science:

  • Immunology
  • Hematology
  • Microbiology

Background:

  • The coagulation and contact systems are integral to innate immunity, controlling bleeding and pathogen spread.
  • These systems also contribute to host defense through inflammatory responses and antimicrobial peptide release.

Purpose of the Study:

  • To investigate the impact of Streptococcus pneumoniae on the coagulation and contact systems.
  • To elucidate the mechanisms by which pneumococci influence blood coagulation.

Main Methods:

  • Studied the effect of S. pneumoniae, specifically its autolysis and pneumolysin release, on blood coagulation.
  • Investigated the interaction of pneumolysin with coagulation and contact system factors.
  • Examined the lysis of mononuclear cells and their procoagulant microvesicles.

Main Results:

  • S. pneumoniae, unlike other streptococci, impairs blood coagulation.
  • Pneumolysin released by pneumococci causes lysis of tissue factor-producing mononuclear cells and their microvesicles.
  • Pneumolysin binds to coagulation and contact system factors without causing activation.

Conclusions:

  • S. pneumoniae modulates coagulation system activation via pneumolysin release.
  • This modulation, particularly the lysis of mononuclear cells, may exacerbate lung injury in pneumococcal pneumonia.
  • Understanding this interaction is crucial for innate immunity and sepsis research.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
487
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
872
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.1K